Loading
A liver MRI dye based on manganese that was authorised in Europe from 1997 to 2012 for finding liver metastases and liver cancer, and is no longer available.
The EMA register lists Teslascan (GE Healthcare AS, EMEA/H/C/000137), authorised on 22 May 1997 as a "Contrast medium for diagnostic magnetic resonance imaging (MRI) for the detection of lesions of the liver suspected to be due to metastatic disease or hepatocellular carcinomas" and an adjunct for focal pancreatic lesions, with the authorisation withdrawn on 21 June 2012. ATC V08CA05. Liver-specific imaging is now done with gadoxetate.
A manganese chelate taken up by liver cells, brightening normal liver on MRI so lesions without normal liver cells stand out.
| Region | Year | Indication |
|---|---|---|
| EU | 1997 | MRI detection of liver lesions suspected to be metastases or hepatocellular carcinoma; adjunct for focal pancreatic lesions · Withdrawn 21 Jun 2012; GE Healthcare AS |
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Mangafodipir" OR ABSTRACT:"Mangafodipir" OR TITLE:"withdrawn liver MRI contrast" OR ABSTRACT:"withdrawn liver MRI contrast" OR TITLE:"Teslascan" OR ABSTRACT:"Teslascan" OR TITLE:"mangafodipir" OR ABSTRACT:"mangafodipir" OR TITLE:"mangafodipir trisodium" OR ABSTRACT:"mangafodipir trisodium") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Mangafodipir (withdrawn liver MRI contrast), not a curated reading list.
Shares Gadolinium-based and other MRI contrast agents, GE HealthCare, MRI and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, GE HealthCare, MRI and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, GE HealthCare, MRI and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI, Hepatocellular carcinoma and the tags contrast-agents-gaps-2026-11, diagnostic.
Shares Gadolinium-based and other MRI contrast agents, MRI and the tags contrast-agents-gaps-2026-11, diagnostic.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/